cisplatin,pemetrexed,pembrolizumab,gemcitabine
merck
['kn671', 'nsclc', 'embrace i', 'pembro', 'sclc', 'lcsm,(-blcsm)']
 #kn671: neoadj pembro-ct + adj pembro in stage ii-iii #nsclc pcr 18 vs 4% 92 vs 84% complete resection better survival without progression or death (2yefs 62 vs 40%) surgeons, embrace immunotherapy!
#lcsm #asco2023 
MD, Medical Oncologist @ospNiguarda and Researcher @LaStatale #LCSM #ThoracicOncology Always find a way to have fun!